UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 5
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
[ ] Check box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue.
[ ] Form 3 Holdings Reported
[ ] Form 4 Transactions Reported
1. Name and Address of Reporting Person(s)
Henneman, III, John B.
311 Enterprise Drive
Plainsboro, New Jersey 08536
2. Issuer Name and Ticker or Trading Symbol
Integra LifeSciences Holdings Corp. (IART)
3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary)
4. Statement for Month/Year
12/02
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
[ ] Director [ ] 10% Owner
[X] Officer (give title below) [ ] Other (specify below)
Sr. V.P., Chief Admin. Officer
and Secretary
7. Individual or Joint/Group Filing (Check Applicable Line)
[X] Form filed by One Reporting Person
[ ] Form filed by More than One Reporting Person
Table I Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Security 2)Trans- 3.Trans- 4.Securities Acquired(A) 5)Amount of 6) 7)Nature of
action action or Disposed of (D) Securities Indirect
Date Code A Beneficially D Beneficial
(Month/ or Owned at or Ownership
Day/Year) Code Amount D Price End of Year I
------------------------------------------------------------------------------------------------------------------------------------
Table II (PART 1) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1 through 6)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 2)Conversion 3)Trans- 4)Trans- 5)Number of Derivative 6)Date Exercisable and
Security or Exercise action action Securities Acquired (A) Expiration Date
Price of Date Code or Disposed of (D)
Derivative
Security Code A D Exercisable Expiration
------------------------------------------------------------------------------------------------------------------------------------
Incentive Stock Option (right $14.8700 08/02/02 A 835 (1) 08/02/08
to buy)
Incentive Stock Option (right $14.8700 08/02/02 A 834 (1) 08/02/08
to buy)
Non-Qualified Stock Option $14.8700 08/02/02 A 4,165 (1) 08/02/08
(right to buy)
Non-Qualified Stock Option $14.8700 08/02/02 A 4,166 (1) 08/02/08
(right to buy)
Table II (PART 2) Derivative Securitites Acquired, Disposed of, or Beneficially Owned (Columns 1,3 and 7 through 11)
------------------------------------------------------------------------------------------------------------------------------------
1)Title of Derivative 3)Trans- 7)Title and Amount 8)Price 9)Number of 10) 11)Nature of
Security action of Underlying of Deri- Derivative Indirect
Date Securities vative Securities D Beneficial
Amount or Security Beneficially or Ownership
Number of Owned at I
- Title Shares End of Year
------------------------------------------------------------------------------------------------------------------------------------
Incentive Stock Option (right 08/02/02 Common Stock 835 D Direct
to buy)
Incentive Stock Option (right 08/02/02 Common Stock 834 1,669 D Direct
to buy)
Non-Qualified Stock Option 08/02/02 Common Stock 4,165 D Direct
(right to buy)
Non-Qualified Stock Option 08/02/02 Common Stock 4,166 8,331 D Direct
(right to buy)
Explanation of Responses:
(1)
25% of the options vest one year after the grant date, with the remaining 75% vesting monthly thereafter over 36 months
SIGNATURE OF REPORTING PERSON
/S/ Henneman, III, John B.
DATE 02/10/03